Abstract | BACKGROUND: PATIENT: RESULTS: While the patient was hospitalized with recurrent facial paralysis, we found that serum levels of free thyroxine (1.3 ng/dL) and thyrotropin (0.4 uIU/mL) were within normal range, but the level of antithyroperoxidase antibodies (772.0 IU/mL) was very increased. She had been taking an oral prednisolone orally for 2 weeks. At the 1-month follow-up, the patient's symptoms had completely disappeared. DISCUSSION:
|
Authors | Yun-Jin Lee, Chong Kun Cheon, Gyu Min Yeon, Young Mi Kim, Sang Ook Nam |
Journal | Pediatric neurology
(Pediatr Neurol)
Vol. 50
Issue 5
Pg. 503-6
(May 2014)
ISSN: 1873-5150 [Electronic] United States |
PMID | 24656464
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2014 Elsevier Inc. All rights reserved. |
Chemical References |
- Anti-Inflammatory Agents
- Prednisolone
|
Topics |
- Anti-Inflammatory Agents
(therapeutic use)
- Autoimmune Diseases
(blood, drug therapy, pathology)
- Child
- Face
(pathology)
- Female
- Follow-Up Studies
- Hashimoto Disease
(blood, complications, drug therapy, pathology)
- Humans
- Melkersson-Rosenthal Syndrome
(blood, complications, drug therapy, pathology)
- Prednisolone
(therapeutic use)
- Tongue
(pathology)
- Treatment Outcome
|